InvestorsHub Logo
Followers 3
Posts 488
Boards Moderated 0
Alias Born 05/31/2013

Re: techxen post# 9127

Thursday, 06/15/2017 11:07:34 AM

Thursday, June 15, 2017 11:07:34 AM

Post# of 27424
Compelling statement:

Shock reversal was achieved in 13 (65%) patients; 28-day survival was 45%. In severe septic shock unresponsive to standard treatment, haemodynamic stabilization was achieved using cytokine adsorption therapy, resulting in shock reversal in two-thirds of these patients. The study was registered in the German Register for Clinical Trials (DRKS) No. 00005149.

https://www.ncbi.nlm.nih.gov/pubmed/28589286

Isn't this enough to demand approval in the USA if you were a ICU physician???
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News